Global Digital Breast Tomosynthesis Report Thumbnail

Global Digital Breast Tomosynthesis Market by End Use (Diagnostic Centers, Hospitals), by Product (Standalone 3D, 2D/3D Combination) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: MD-74365
  • Author: Up Market Research
  • Rating: 4.8
  • Total Reviews: 83
  • No. Of Pages: 242
  • Format:
  • Pub. Date: 2021-10-21
  • Share:

Summary of the Report

Global digital breast tomosynthesis market was valued at USD 1.41 million in 2018. It is expected to grow at a CAGR 13.5% during the forecast period. This is due to technological advances, increasing awareness about tomosynthesis and an increase in breast cancer cases around the world.

According to the World Health Organization (WHO), breast cancer afflicted approximately 627,000 women worldwide in 2018. It is also estimated that the incidence of the disease is higher in developed than in developing countries. DBT screening is more efficient and convenient than 2D mammograms. This is why there is expected to be an increase in demand for these products over the forecast period.

According to the American Journal of Roentgenology, in 2014, relative changes in recall rates were 16.1% lower for patients screened using 3D digital breasttomosynthesis (AJR) than in patients screened using 2D digital mammograms. These factors will drive market growth during the forecast period.

Market growth will also be boosted by increased awareness of the advantages of DBT over traditional systems.

According to Konica Minolta Health Americas, Inc. in 2016, the efficiency in DBT screening for invasive cancer has increased to nearly 50.0%. Digital breast tomosynthesis market growth is being driven by key companies that are investing in product and technological innovations for greater efficiency and precision. Fujifilm, for example, launched three new software tools in March 2019 for its ASPIRE Cristalle digital mammography system to improve efficiency.

Product Insights

The market can be divided into two types of products: standalone 3D systems and 2D/3D combination. In 2018, the most popular product segment was standalone 3D systems. The key drivers of this segment are the increasing prevalence of breast cancer around the world and increased awareness about standalone DBT 3D system. According to the American Cancer Society in the United States, there were approximately 63,410 cases in situ and 252,710 cases of breast cancer invasive in 2017.

According to Konica Minolta Healthcare Americas, Inc., standalone 3-D systems can overcome limitations of 2D mammography systems in terms precision, efficiency, as well as sensitivity. This report will propel the segment's growth. The segment 2D/3D combination system is expected to see the most growth during the forecast period. This segment is driven by rising awareness of the benefits of using these systems.

According to the American Society of Clinical Oncology's (ASCO) study, 2016 saw a decrease in the detection rate of 2D/3D combination systems by almost 28.0% and a 16.0% drop in recall rates.

End-Use Information

The market can be divided into diagnostic centers, hospitals, and other segments based on end-use. Due to rising breast cancer prevalence and increasing healthcare spending in developing countries, the hospitals segment dominated in 2018. According to the India Brand Equity Foundation (IBEF), the Indian hospital industry will generate USD 132.84 trillion in revenue by 2022. These factors will positively influence the segment's growth during the forecast period.

The segment of diagnostics centers is expected to experience the fastest growth during the forecast period. The segment is expected to grow due to the increasing number of diagnostics centres around the world. According to the India Brand Equity Foundation in 2018, foreign direct investment (FDI), made approximately USD 6.0 billion in hospitals and diagnostics centers between April 2000-December 2018.

Regional Insights

In 2018, North America was the dominant market for global products and will continue to be so in the future. The North American market is driven by the rising incidence of breast cancer. Market growth is expected to be driven by the strong healthcare infrastructure in the region and rising healthcare spending. Asia Pacific will be the fastest-growing region market during the forecast period, as major companies seek to enter emerging countries.

Digital Breast Tomosynthesis Market Share insights

Hologic, Inc., GE Healthcare, Siemens Healthineers, Fujifilm Corp. are some of the most prominent companies in this market. To strengthen their market position, these companies have used strategies such as product development and mergers & acquisitions.

True Breast Tomosynthesis of Siemens Healthineers was approved by the FDA in April 2015. This allowed the company to expand its customer base. In September 2014, 3D Breast Imaging of GE Healthcare was approved by the FDA. This further accelerated demand for 3D Breast Tomosynthesis Imaging System.

Digital Breast Tomosynthesis Market Report Scope

The Report Covers Certain Segments

This report provides a forecast of revenue growth at the global, regional and country level and analyzes the most recent industry trends in each sub-segment from 2014 to 2026. Grand View Research has divided the global digital breasttomosynthesis market report by product, region, and end-use.

  • Product Outlook (Revenue USD Million, 2014-2026)

    • 2D/3D Combination Systems

    • Standalone 3D Systems

  • End-Use Outlook (Revenue USD Million, 2014-2026)

    • Hospitals

    • Diagnostics Centers

    • Other

  • Regional Outlook (Revenue USD Million, 2014-2026)

    • North America

      • The U.S.

      • Canada

    • Europe

      • The U.K.

      • Germany

    • Asia-Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Up Market Research published a new report titled “Digital Breast Tomosynthesis Market research report which is segmented by End Use (Diagnostic Centers, Hospitals), by Product (Standalone 3D, 2D/3D Combination), By Players/Companies merger & acquisitions, Hologic, such as product development, partnerships to strengthen their foothold in the market, Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report AttributesReport Details
Report TitleDigital Breast Tomosynthesis Market Research Report
By End UseDiagnostic Centers, Hospitals
By ProductStandalone 3D, 2D/3D Combination
By Companiesmerger & acquisitions, Hologic, such as product development, partnerships to strengthen their foothold in the market, Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages242
Number of Tables & Figures170
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Digital Breast Tomosynthesis Industry Outlook

Global Digital Breast Tomosynthesis Market Report Segments:

The market is segmented by End Use (Diagnostic Centers, Hospitals), by Product (Standalone 3D, 2D/3D Combination).

Digital Breast Tomosynthesis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Digital Breast Tomosynthesis Market

Overview of the regional outlook of the Digital Breast Tomosynthesis Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Digital Breast Tomosynthesis Market Overview

Highlights of The Digital Breast Tomosynthesis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Digital Breast Tomosynthesis Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
        6. By End Use:

                1. Diagnostic Centers

                2. Hospitals

        7. By Product:

                1. Standalone 3D

                2. 2D/3D Combination

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Digital Breast Tomosynthesis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Digital Breast Tomosynthesis Market Trends

Reasons to Purchase the Digital Breast Tomosynthesis Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digital Breast Tomosynthesis Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Digital Breast Tomosynthesis Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Digital Breast Tomosynthesis Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Digital Breast Tomosynthesis Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Digital Breast Tomosynthesis Market Size & Forecast, 2018-2028 
      4.5.1 Digital Breast Tomosynthesis Market Size and Y-o-Y Growth 
      4.5.2 Digital Breast Tomosynthesis Market Absolute $ Opportunity 


Chapter 5 Global Digital Breast Tomosynthesis Market Analysis and Forecast by End Use
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by End Use
      5.1.2 Basis Point Share (BPS) Analysis by End Use
      5.1.3 Absolute $ Opportunity Assessment by End Use
   5.2 Digital Breast Tomosynthesis Market Size Forecast by End Use
      5.2.1 Diagnostic Centers
      5.2.2 Hospitals
   5.3 Market Attractiveness Analysis by End Use

Chapter 6 Global Digital Breast Tomosynthesis Market Analysis and Forecast by Product
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Product
      6.1.2 Basis Point Share (BPS) Analysis by Product
      6.1.3 Absolute $ Opportunity Assessment by Product
   6.2 Digital Breast Tomosynthesis Market Size Forecast by Product
      6.2.1 Standalone 3D
      6.2.2 2D/3D Combination
   6.3 Market Attractiveness Analysis by Product

Chapter 7 Global Digital Breast Tomosynthesis Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Digital Breast Tomosynthesis Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Digital Breast Tomosynthesis Analysis and Forecast
   9.1 Introduction
   9.2 North America Digital Breast Tomosynthesis Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Digital Breast Tomosynthesis Market Size Forecast by End Use
      9.6.1 Diagnostic Centers
      9.6.2 Hospitals
   9.7 Basis Point Share (BPS) Analysis by End Use 
   9.8 Absolute $ Opportunity Assessment by End Use 
   9.9 Market Attractiveness Analysis by End Use
   9.10 North America Digital Breast Tomosynthesis Market Size Forecast by Product
      9.10.1 Standalone 3D
      9.10.2 2D/3D Combination
   9.11 Basis Point Share (BPS) Analysis by Product 
   9.12 Absolute $ Opportunity Assessment by Product 
   9.13 Market Attractiveness Analysis by Product

Chapter 10 Europe Digital Breast Tomosynthesis Analysis and Forecast
   10.1 Introduction
   10.2 Europe Digital Breast Tomosynthesis Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Digital Breast Tomosynthesis Market Size Forecast by End Use
      10.6.1 Diagnostic Centers
      10.6.2 Hospitals
   10.7 Basis Point Share (BPS) Analysis by End Use 
   10.8 Absolute $ Opportunity Assessment by End Use 
   10.9 Market Attractiveness Analysis by End Use
   10.10 Europe Digital Breast Tomosynthesis Market Size Forecast by Product
      10.10.1 Standalone 3D
      10.10.2 2D/3D Combination
   10.11 Basis Point Share (BPS) Analysis by Product 
   10.12 Absolute $ Opportunity Assessment by Product 
   10.13 Market Attractiveness Analysis by Product

Chapter 11 Asia Pacific Digital Breast Tomosynthesis Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Digital Breast Tomosynthesis Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Digital Breast Tomosynthesis Market Size Forecast by End Use
      11.6.1 Diagnostic Centers
      11.6.2 Hospitals
   11.7 Basis Point Share (BPS) Analysis by End Use 
   11.8 Absolute $ Opportunity Assessment by End Use 
   11.9 Market Attractiveness Analysis by End Use
   11.10 Asia Pacific Digital Breast Tomosynthesis Market Size Forecast by Product
      11.10.1 Standalone 3D
      11.10.2 2D/3D Combination
   11.11 Basis Point Share (BPS) Analysis by Product 
   11.12 Absolute $ Opportunity Assessment by Product 
   11.13 Market Attractiveness Analysis by Product

Chapter 12 Latin America Digital Breast Tomosynthesis Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Digital Breast Tomosynthesis Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Digital Breast Tomosynthesis Market Size Forecast by End Use
      12.6.1 Diagnostic Centers
      12.6.2 Hospitals
   12.7 Basis Point Share (BPS) Analysis by End Use 
   12.8 Absolute $ Opportunity Assessment by End Use 
   12.9 Market Attractiveness Analysis by End Use
   12.10 Latin America Digital Breast Tomosynthesis Market Size Forecast by Product
      12.10.1 Standalone 3D
      12.10.2 2D/3D Combination
   12.11 Basis Point Share (BPS) Analysis by Product 
   12.12 Absolute $ Opportunity Assessment by Product 
   12.13 Market Attractiveness Analysis by Product

Chapter 13 Middle East & Africa (MEA) Digital Breast Tomosynthesis Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Digital Breast Tomosynthesis Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Digital Breast Tomosynthesis Market Size Forecast by End Use
      13.6.1 Diagnostic Centers
      13.6.2 Hospitals
   13.7 Basis Point Share (BPS) Analysis by End Use 
   13.8 Absolute $ Opportunity Assessment by End Use 
   13.9 Market Attractiveness Analysis by End Use
   13.10 Middle East & Africa (MEA) Digital Breast Tomosynthesis Market Size Forecast by Product
      13.10.1 Standalone 3D
      13.10.2 2D/3D Combination
   13.11 Basis Point Share (BPS) Analysis by Product 
   13.12 Absolute $ Opportunity Assessment by Product 
   13.13 Market Attractiveness Analysis by Product

Chapter 14 Competition Landscape 
   14.1 Digital Breast Tomosynthesis Market: Competitive Dashboard
   14.2 Global Digital Breast Tomosynthesis Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 merger & acquisitions
      14.3.2 Hologic
      14.3.3 such as product development
      14.3.4 partnerships to strengthen their foothold in the market
      14.3.5 Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies
Segments Covered in the Report
The global Digital Breast Tomosynthesis market has been segmented based on

By End Use
  • Diagnostic Centers
  • Hospitals
By Product
  • Standalone 3D
  • 2D/3D Combination
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • merger & acquisitions
  • Hologic
  • such as product development
  • partnerships to strengthen their foothold in the market
  • Inc; GE Healthcare; Siemens Healthineers; Dexela Ltd; and Fujifilm Corp These companies have adopted strategies

Buy Report